Abstract
Cumulative exposure to hypertension is an adverse prognostic marker. However, longitudinal assessments of blood pressure (BP) control, e.g., TIme at TaRgEt (TITRE), are not routinely assessed. We determined whether low-dose triple combination antihypertensive therapy achieved greater TITRE compared to usual care.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
